Lukas Geary

403 total citations
9 papers, 229 citations indexed

About

Lukas Geary is a scholar working on Cellular and Molecular Neuroscience, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Lukas Geary has authored 9 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cellular and Molecular Neuroscience, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Oncology. Recurrent topics in Lukas Geary's work include Neuropeptides and Animal Physiology (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Acute Ischemic Stroke Management (2 papers). Lukas Geary is often cited by papers focused on Neuropeptides and Animal Physiology (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Acute Ischemic Stroke Management (2 papers). Lukas Geary collaborates with scholars based in Sweden and United States. Lukas Geary's co-authors include Robert C.A. Frederickson, Kathryn S. Wiley, A Meister, Marlene L. Cohen, Geoff Kerchner, Martine Cohen, William L. Scott, Jan Hasselström, Mia von Euler and Clas Rehnberg and has published in prestigious journals such as Journal of Biological Chemistry, Progress in Neurobiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lukas Geary

9 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukas Geary Sweden 8 118 95 49 29 20 9 229
Shihao Xu China 7 125 1.1× 93 1.0× 87 1.8× 17 0.6× 29 1.4× 14 339
Ginger L. Becker United States 6 98 0.8× 96 1.0× 45 0.9× 6 0.2× 9 0.5× 9 268
Teh‐Ching Chu United States 12 98 0.8× 181 1.9× 50 1.0× 10 0.3× 5 0.3× 31 339
Tetsuya Kanno Japan 11 199 1.7× 189 2.0× 48 1.0× 11 0.4× 13 0.7× 16 426
Anne Renouard France 9 191 1.6× 212 2.2× 86 1.8× 28 1.0× 9 0.5× 10 373
G A Buckley United Kingdom 11 149 1.3× 140 1.5× 71 1.4× 17 0.6× 13 0.7× 30 373
C Dumont France 11 182 1.5× 110 1.2× 54 1.1× 6 0.2× 24 1.2× 35 429
Daniel Cavey France 8 161 1.4× 235 2.5× 23 0.5× 9 0.3× 10 0.5× 12 363
Seung Woo Shin South Korea 10 83 0.7× 101 1.1× 77 1.6× 12 0.4× 12 0.6× 19 333
Helmut Gottlieb United States 9 66 0.6× 125 1.3× 47 1.0× 17 0.6× 16 0.8× 19 327

Countries citing papers authored by Lukas Geary

Since Specialization
Citations

This map shows the geographic impact of Lukas Geary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Geary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Geary more than expected).

Fields of papers citing papers by Lukas Geary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Geary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Geary. The network helps show where Lukas Geary may publish in the future.

Co-authorship network of co-authors of Lukas Geary

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Geary. A scholar is included among the top collaborators of Lukas Geary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Geary. Lukas Geary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Geary, Lukas, Jan Hasselström, Axel C. Carlsson, Karin Schenck‐Gustafsson, & Mia von Euler. (2020). An audit & feedback intervention for improved anticoagulant use in patients with atrial fibrillation in primary care. International Journal of Cardiology. 310. 67–72. 2 indexed citations
2.
Geary, Lukas, Jan Hasselström, Axel C. Carlsson, I Eriksson, & Mia von Euler. (2019). Secondary prevention after stroke/transient ischemic attack: A randomized audit and feedback trial. Acta Neurologica Scandinavica. 140(2). 107–115. 8 indexed citations
4.
Geary, Lukas, et al.. (2017). Sociodemographic factors are associated with utilisation of statins after ischaemic stroke/TIA. International Journal of Clinical Practice. 71(3-4). e12936–e12936. 8 indexed citations
5.
Cohen, Marlene L., Lukas Geary, & Kathryn S. Wiley. (1983). Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.. Journal of Pharmacology and Experimental Therapeutics. 224(2). 379–385. 30 indexed citations
6.
Kerchner, Geoff & Lukas Geary. (1983). Studies on the transport of enkephalin-like oligopeptides in rat intestinal mucosa.. Journal of Pharmacology and Experimental Therapeutics. 226(1). 33–38. 17 indexed citations
7.
Geary, Lukas, Kathryn S. Wiley, William L. Scott, & Martine Cohen. (1982). Degradation of exogenous enkephalin in the guinea-pig ileum: relative importance of aminopeptidase, enkephalinase and angiotensin converting enzyme activity.. Journal of Pharmacology and Experimental Therapeutics. 221(1). 104–111. 30 indexed citations
8.
Frederickson, Robert C.A. & Lukas Geary. (1982). Endogenous opioid peptides: review of physiological, pharmacological and clinical aspects. Progress in Neurobiology. 19(1-2). 19–69. 89 indexed citations
9.
Geary, Lukas & A Meister. (1977). On the mechanism of glutamine-dependent reductive amination of alpha-ketoglutarate catalyzed by glutamate synthase.. Journal of Biological Chemistry. 252(10). 3501–3508. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026